Brain Metastasis in Clinical Trials
Explore the dynamic landscape of oncology clinical development in the recent article, “Brain Metastasis in Clinical Trials,” highlighting insights from the distinguished Neuro-Oncology expert, Dr. Mariko DeWire-Schottmiller.
In this high-demand article, Dr. DeWire-Schottmiller delves into the obstacles faced in neuro-oncology clinical trials, recent breakthroughs, and the future of oncology clinical research, including enhanced accessibility and improved outcomes for patients with CNS tumors.
Hematology & Oncology
An integrated Approach
With our proven full-service outsourcing model, Medpace delivers high-quality results. In the competitive field of hematology and oncology, we have earned a reputation for taking on some of the most complex and challenging cancer research studies.
- Global, in-house medical experts across a wide range of therapeutic areas, including hematology and oncology, and global regions, including Asia Pacific, Europe, and the US—demonstrated by 250+ hematology and oncology trials
- Comprehensive regulatory affairs and operational experts who work collaboratively with our medical team
- Expedited start-up and recruitment, including long-term site relationships and preferred CRO status with key Phase I hematology and oncology centers
- Integrated tumor imaging and central laboratory services, ensuring seamless logistics, review, and testing